Bharat Biotech gets DGCI nod for intranasal Covid booster doses
The Drugs Controller General of India (DCGI) on Friday gave its permission to Bharat Biotech for conducting trials of intranasal booster doses against the coronavirus disease (Covid-19).
According to an input from news agency ANI, the…
Read More...
Read More...